Search
Aclaris Therapeutics Inc
ACRSAdd to Watchlist
5.250USD
+0.050+0.96%
Close 07-31 16:00（ET）Quotes delayed by 15 min
733.18MMarket Cap
LossP/E TTM
Aclaris Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Aclaris Therapeutics Inc is 7.13, ranking 213 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -9.28, which is -95.84% below the recent high of -0.39 and -45.14% above the recent low of -13.47.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.